Analyst Ratings for Q32 Bio Inc. (QTTB)
QTTB Rating Summary
QTTB Price Target Summary
- Highest: $20.00 (Oppenheimer)
- Lowest: $13.00 (H.C. Wainwright)
- Average: $16.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$16.50 (+251.1%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$16.50 (+251.1%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | H.C. Wainwright | Joseph Pantginis | New Coverage | Buy (N/A) |
13.00 (N/A) |
4.50 (4.70) |
4.44% | Details |
| 2/11/2025 | BMO Capital | Etzer Darout | Downgrade | Market Perform (Outperform) |
3.00 (22.00) |
3.18 (4.70) |
47.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
